Regeneron and Moderna Are Both Outperforming Today

Regeneron, Moderna, and COVID-19
The spread of COVID-19, minute creatures that seem to be trying to defeat us, has been accused of bringing the market down over 1000 points yesterday.

Investors who love the biotech stocks they carefully and accurately hand-picked should take advantage of the temporary market drop to buy more of their preferred stocks at bargain prices. In so doing, the cost of purchasing the stocks drops, hence, swelling their gains. This is true when the stocks belong to companies that have solid scientific and technological fundamentals in addition to capable professional management . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.